Trending:
Nabriva Therapeutics’ intravenous (IV) and per oral (PO) lefamulin for community-acquired bacterial pneumonia (CABP), one of the most common infectious diseases, has experts anticipating limited market uptake for both following a...
The Brexit process has a long way to go, as a vote of approval from the UK Parliament, which is expected to occur in December 2018, is still needed for...
External Reference Pricing is the practice of using the price of a product in foreign countries to derive a benchmark for setting or negotiating the price of a product within...
In 2017, the FDA approved 80 drugs with orphan drug designation. GlobalData’s Pharma Intelligence Center database covers the clinical trials for those 80 drugs, including a key analysis of the...
Researchers have recently discovered that "magic mushrooms" may help treat major depressive disorder due to their active ingredient, psilocybin.
The Peptides and Proteins Lab at the Institute for Research in Biomedicine has discovered the capacity of a small protein, found in scorpion venom, to carry drugs across the blood–brain...
Over the past few years, Pfizer has tried using aggressive strategies to extend its flagship brand Lyrica's lifecycle and protect it from generic competition.
Krystal Biotech's Phase I/II trial of topical gene therapy, KB103, for dystrophic epidermolysis bullosa (DEB) is recruiting two more adult patients on top of its original four-patient target.
In July 2012, the Generating Antibiotic Incentives Now (GAIN) Act was signed into law by the Obama administration as part of the FDA Safety and Innovation Act. Since then, there...
On 15 November, SOBI presented at the Jefferies Healthcare Conference 2018 in London. SOBI’s president and chief executive officer, Guido Oelkers, hailed the successful launch of its haemophilia products as...
Go Top
